🔴 clinicians should consider #risankizumab in patients with moderate-to-severely active #CD despite use of prior #biologic #therapies as well as in those who are #steroid dependent 🔴 Robert Dudkowiak MD, PhD Jan Král ignacio catalan Patriciakaazan #MedEd #MedTwitter #IBD #Crohn